Managing Pulmonary Hypertension

               

CLICK HERE TO JOIN ME

Pulmonary hypertension is a major concern for patients admitted in ICUs for respiratory distress and cardiac ailments. The management of pulmonary hypertension needs proper evaluation of the symptoms together with the co-existing morbidities to support faster recovery and prevent complications.

While patients with respiratory diseases like pulmonary hypertension (PH) do not appear to be at a higher risk for contracting COVID-19, they might be more likely to develop serious chest infections due to the exposure to the virus. 

Healthcare practitioners, hence, need to take extra precautions to minimize the patient's risk of COVID-19. They also need to train and educate patients and their families about the precautions they should take in order to avoid complications related to pulmonary hypertension as well as COVID-19.

Generally, it is advisable for patients to:

·         Stock up on all prescription medications and supplies to last for a few weeks.

·         Stay at home as much as possible

·         Avoid visiting crowded places

·         Avoid non-essential travel

Those with existing respiratory issues should wear a face mask only when necessary as it might make breathing more difficult for them. 

There are several treatments for pulmonary hypertension including medications and surgeries. The patient may be advised one or more medications depending on a number of factors, including the causes of PH and the severity of symptoms.

Treatments usually include anticoagulant medicines like warfarin to prevent blood clots, or diuretics to remove excess fluids from the body. Digoxin can help to improve the symptoms by slowing down the heart rate and strengthening the cardiac muscle contractions.

Critical care of patients with pulmonary hypertension in ICU usually includes mechanical or non-mechanical ventilation depending on the extent of breathing difficulties.

Other treatments recommended for PH include endothelin receptor antagonists, phosphodiesterase 5 inhibitors, prostaglandins, soluble guanylate cyclase stimulators, and calcium channel blockers. 

Some patients with PH may need surgery. For example; pulmonary endarterectomy is aimed at removing abnormal blood clots in the pulmonary arteries in patients having chronic thromboembolic pulmonary hypertension.

Atrial septostomy and balloon pulmonary angioplasty can also be performed in some patients when medications fail to produce the desired results. Lung transplantation may be recommended only in severe cases.

 

You can learn more about the management of PH at our ‘Critical Care Webinar’ being conducted on 6th November from 10 am to 3 pm. We will discuss the various treatments and protocols for the management of PH in the ICU settings as well as at home. You will also learn about how to train patients to care for themselves after discharge.

The other topics discussed during this respiratory conference include sedation and analgesia monitoring in ICU patients, and ventilator management of patients with ARDS. We will also discuss the ICU protocols aimed at improving outcomes.

Our panel of expert physicians will share with you some case studies of ICU patients to help you understand the topics with a practical view.

Join the webinar to keep yourself updated about critical care and management to improve your skills and knowledge.

 

Popular posts from this blog

RESPIRATORY THERAPY TOPICS ON SLEEP MEDICINE WEBINAR

A & T Lectures Sleep Medicine Webinar Respiratory Conference that is considered live or traditional CEU’s. You can interact and ask questions after the presentation. Hosted by A & T Lectures Using Zoom Video Communications We will be offering 5 Live/Webinar AARC approved CEU’s October 22 @ 4:00 pm - 9:00 pm  CONFERENCE SCHEDULE AND INSTRUCTION ON ACCESSING THIS WEBINAR Register for the conference Special note: You can join the conference for free but only those that register will get the 5 CEU’s Download ZOOM to your computer or laptop/desktop (its free) Practice using ZOOM with a friend before entering the webinar as this will not be the right time to teach you how to access the conference Make sure you join the webinar by accessing this link 10 minutes before the conference. Join The Webinar
Read more

Pulmonary Fibrosis – Symptoms, Causes, Stages, and Treatment

Image
Pulmonary fibrosis is a lung disorder that occurs when the tissues in the lungs become damaged followed by scarring. Scaring results in the formation of thick and stiff tissue that makes it more difficult for the lungs to expand and relax preventing them from working properly. As pulmonary fibrosis becomes worsens, the patient becomes short of breath in a progressive manner. The scarring linked to pulmonary fibrosis is often caused due to a combination of factors. However, in most cases, it is difficult to detect the exact cause that triggered the development of this condition. When no specific cause can be found, the condition is called idiopathic pulmonary fibrosis. The damage caused due to pulmonary fibrosis cannot be reversed. However, medications and treatment may sometimes help to ease the symptoms and improve the patient's quality of life. In some patients, a lung transplant may be required. Stages of pulmonary fibrosis Stage 1: Recent diagnosis The common early
Read more

Management Of Respiratory Failure In COVID Patients

Image
Management Of Respiratory Failure In COVID Patients It’s been more than 8 months now and still, the COVID-19 pandemic shows no sign of decline in the number of cases. What makes the COVID-19 pandemic a major cause of concern is the high risk of mortality associated with it, particularly due to respiratory failure. COVID-19 has a higher tropism for the lung and is known to cause severe pneumonia and ARDS (acute respiratory distress syndrome), especially in patients with a weak immune system and existing co-morbidities. This marks the need for the physicians, nurses, and healthcare workers to stay abreast of the latest information about the risk of ARDS and the recommended protocol for the management of respiratory distress in COVID-19 patients. Clinical features of ARDS in COVID-19 patents Most patients with COVID-induced respiratory distress meet the Berlin definition of ARDS. However, some patients may exhibit a different phenotype of ARDS with lower lung weight, higher lu
Read more